Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Pharmacology in Drug Development|September 5, 2022
Drug-Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 (Bersacapavir)Joris Vandenbossche, Jeysen Yogaratnam, Vera Hillewaert, et al.Antimicrobial Agents and Chemotherapy|October 4, 2017
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir RegimenStefan Bourgeois, Yves Horsmans, Frederik Nevens, et al.Journal of Clinical Pharmacology|February 14, 2023
Pharmacokinetics of JNJ-73763989 and JNJ-56136379 (Bersacapavir) in Participants With Moderate Hepatic ImpairmentThomas N Kakuda, Atef Halabi, Gernot Klein, et al.Antiviral Therapy|June 13, 2022
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis BEd Gane, Man-Fung Yuen, Thomas N Kakuda, et al.Journal of Pharmaceutical Sciences|April 27, 2016
Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of FlubendazoleMonica Vialpando, Stefanie Smulders, Scott Bone, et al.Pageof 2